Compare NSYS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSYS | MYO |
|---|---|---|
| Founded | 1981 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 44.8M |
| IPO Year | 1996 | 2017 |
| Metric | NSYS | MYO |
|---|---|---|
| Price | $12.46 | $1.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 14.6K | ★ 517.0K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.85 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | $14,371,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | $141.67 | ★ N/A |
| Revenue Growth | 7.01 | ★ 40814.79 |
| 52 Week Low | $6.50 | $0.61 |
| 52 Week High | $18.01 | $1.59 |
| Indicator | NSYS | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 38.56 | 74.71 |
| Support Level | $11.94 | $0.69 |
| Resistance Level | $15.35 | N/A |
| Average True Range (ATR) | 1.06 | 0.14 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 7.98 | 97.45 |
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.